Inloggad som:
MK-2870-009
Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
MK-2870-009
A Randomized Phase 3 Study of MK-2870 plus Platinum vs. MK-2870 vs. Platinum Doublets in EGFR-mutated, Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) Participants Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors
A Randomized Phase 3 Study of MK-2870 plus Platinum vs. MK-2870 vs. Platinum Doublets in EGFR-mutated, Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) Participants Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors
PLACEHOLDER
Randomisering mellan MK-2870 plus Platinum vs. MK-2870 vs. Platinum Doublets till patienter med EGFR-mutated icke-småcellig lungcancer som har återfall efter behandling med EGFR Tyrosine Kinase hämmare
Mer information om studien för vårdgivare
Studien ändrades senast av: studyjohanna (2024-08-26)